-
JOINT CLINICAL ASSESSMENT, EVOLVING NATIONAL HTA GUIDANCE AND METHODS
Aug 11, 2026, 17:16 PM -
PATIENTS' EXPECTATIONS OF PHARMACOLOGICAL TREATMENTS FOR RHEUMATIC CONDITIONS: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
SICK IN THE CITY? REGIONAL DIFFERENCES AND CAUSES OF SICK LEAVE IN GERMANY: CLAIMS DATA INSIGHTS AND ANALYTICAL OPPORTUNITIES
Aug 11, 2026, 17:16 PM -
BEYOND SINGLE-MODEL SURROGACY: A MULTI-MODEL EVALUATION OF PROGRESSION-FREE SURVIVAL AS A TRIAL-LEVEL SURROGATE FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
UNCERTAINTY WITHOUT CERTAINTY: THE VERDICT THE FIRST ORPHAN JCA NEVER GAVE
Aug 11, 2026, 17:16 PM -
AI-ASSISTED DATA EXTRACTION FOR SYSTEMATIC LITERATURE REVIEWS IN HTA: ACCURACY AND EFFICIENCY WITHIN A NICE-ALIGNED WORKFLOW
Aug 11, 2026, 17:16 PM -
HEALTH TECHNOLOGY ASSESSMENT RELEVANT VALIDATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN FIRST-LINE METASTATIC TRIPLE-NEGATIVE BREAST CANCER: A BAYESIAN META-ANALYTIC FRAMEWORK
Aug 11, 2026, 17:16 PM -
EXPLORING THE IMPLICIT INCLUSION OF INFORMAL CARER SPILLOVERS IN HEALTH STATE VALUATION USING DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
LEARNING WHILE USING: EVIDENCE EXPECTATIONS UNDER NICE'S REFORMED HEALTHTECH PROGRAM
Aug 11, 2026, 17:16 PM -
BIMEKIZUMAB IMPACT ON PAIN AND QUALITY OF LIFE STRATIFIED BY IHS4 LEVELS IN PATIENTS WITH HIDRADENITIS SUPPURATIVA: 3-YEAR RESULTS FROM BE HEARD EXT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A STUDY FROM A JORDANIAN PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COST SAVINGS ASSOCIATED WITH THE INTRODUCTION OF SUBCUTANEOUS VERSUS INTRAVENOUS PEMBROLIZUMAB IN GREECE
Aug 11, 2026, 17:16 PM -
REAL-WORLD CLINICAL INDICATORS PRIOR TO FIRST-LINE TREATMENT INITIATION IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A NORSTELLALINQ CLAIMS AND EHR ANALYSIS
Aug 11, 2026, 17:16 PM -
IDENTIFYING CANDIDATE SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: ESTABLISHING INDIVIDUAL-LEVEL SURROGACY
Aug 11, 2026, 17:16 PM -
INPATIENT BURDEN OF INFLUENZA AND INFLUENZA-LIKE ILLNESS AMONG ADULTS IN GERMANY, 2022-2025
Aug 11, 2026, 17:16 PM -
PUBLISHED CLINICAL AND ECONOMIC EVIDENCE AS A PREREQUISITE FOR ASSESSING THE VALUE OF CONTINUOUS GLUCOSE MONITORING SYSTEMS (CGM)
Aug 11, 2026, 17:16 PM -
MOMELOTINIB RESULTS IN COST SAVINGS VS RUXOLITINIB FOR PATIENTS WITH MYELOFIBROSIS AND MODERATE TO SEVERE ANAEMIA
Aug 11, 2026, 17:16 PM -
MANAGEMENT OF POST-SURGICAL PERIPHERAL NEUROPATHIC PAIN IN ADULTS: A FRENCH SURVEY
Aug 11, 2026, 17:16 PM -
XLGEN: A STRUCTURE-FIRST KNOWLEDGE GRAPH FRAMEWORK FOR AI-ASSISTED QUALITY CONTROL OF EXCEL-BASED BUDGET IMPACT MODELS
Aug 11, 2026, 17:16 PM -
FROM REACTIVE TO PREDICTIVE: A HUMAN-IN-THE-LOOP AI FRAMEWORK FOR ANTICIPATORY PICO SCOPING FOR EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM
